Marketwired News

Pharmaceuticals and Biotech - Drugs

Corbus Pharmaceuticals Initiates "RESOLVE-1" Phase 3 Study in Systemic Sclerosis
December 14, 2017

Effective Implementation of the Revised EMA First-into-Human (FIH) Guidance to Accelerate Your Early Clinical Development, New Webinar Hosted by Xtalks
December 14, 2017

Vernalis PLC: AGM Statement
December 14, 2017

Tetra Bio-Pharma Reinforces its Development Program by Signing Research & Development Agreement with Constance Therapeutics and Receiving Financial Support from NSERC
December 13, 2017

VistaGen Announces Closing of $15,000,000 Underwritten Offering of Common Stock and Warrants to Purchase Common Stock
December 13, 2017

Maricann Group Inc. Announces $20 Million Private Placement
December 13, 2017

Optimize Patient Enrollment by Incorporating Physician Referral Networks in Your Outreach Plan, New Webinar Hosted by Xtalks
December 13, 2017

Vernalis + Daiichi Sankyo Enter Collaboration
December 13, 2017

Maricann Group Inc. Signs Definitive Agreement with Lovell Drugs for Medical Cannabis Retail Pharmacy Initiative
December 12, 2017

Angle PLC: Transfer of Lock-in Shares
December 12, 2017

VistaGen Announces Pricing of Underwritten Offering of Common Stock and Warrants to Purchase Common Stock
December 11, 2017

Rennova Health Announces an Upgrade of MedicalMime's Flagship EHR M2Select to Version 3.3
December 11, 2017

Rising Overdose Deaths in Orange County Prompt New Addiction Treatment Center to Open
December 11, 2017

Strength Sensei Nutraceuticals and Charles R. Poliquin launch MaxSimil®
December 11, 2017

Trillium Therapeutics Provides Update on its TTI-621 Program at the American Society of Hematology 59th Annual Meeting
December 11, 2017

IntelGenx Receives USPTO Notice of Allowance for Montelukast Orange Book Eligible Patent
December 11, 2017

BioVie Receives FDA Fast Track Designation for BIV201 for the Treatment of Refractory Ascites Due to Advanced Liver Cirrhosis
December 11, 2017

Tetra Bio-Pharma provides update on status of its Phase 3 Clinical Trial Application of Lead Drug Candidate PPP001
December 09, 2017

Aequus announces the issuance of stock options
December 08, 2017

VistaGen Therapeutics Expands Stem Cell Patent Portfolio with New U.S. Patent on Methods for Producing Blood Cells, Platelets and Bone Marrow Stem Cells with Potential to Treat Autoimmune Disorders and Cancer
December 08, 2017

ANGLE plc Announces Parsortix Potential in Metastatic Breast Cancer
December 08, 2017

ViaDerma, Inc. Looks to have Sales Representatives Selling its FDA Registered Medication VitaStem to a Network of 1000 Physician Offices Nationwide in 2018
December 07, 2017

Pieris Pharmaceuticals Announces Ethics and Regulatory Clearance to Begin Clinical Testing of Inhaled Respiratory Program, PRS-060/AZD1402
December 07, 2017

Critical Outcome Technologies Annual and Special Meeting of Shareholders Rescheduled
December 06, 2017

Tetra Bio-Pharma Opens Markets at TSX Listing Ceremony
December 06, 2017

Moleculin's WP1066 Drug receives $2 million Private Grant
December 06, 2017

VistaGen Therapeutics Granted U.S. Patent regarding Methods of Production for AV-101
December 06, 2017

Vernalis and Servier Achieve Research Milestone
December 06, 2017

Dynavax Technologies Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
December 05, 2017

NutraFuels, Inc. (NTFU) Provides 3rd Quarter Financials
December 05, 2017

IntelGenx to Regain Exclusive Worldwide Rights to Develop and Commercialize RIZAPORT(R)
December 05, 2017

Vaxil Strengthens Board of Directors and Management Concurrent to $1-Million Financing
December 05, 2017

Moleculin's WP1066 Drug gets FDA Brain Tumor IND Clearance
December 05, 2017

Rennova Health Announces That Big South Fork Medical Center Has Received Its First Payments for Services Provided
December 04, 2017

Revive Therapeutics Announces Update on Development of Datametrex Artificial Intelligence Component in Blockchain Enabled Patient-Focused Program for Medical Cannabis Sector
December 04, 2017

Preclinical Efficacy Data on Sickle Cell Disease of ORY-3001, a LSD1 inhibitor from ORYZON, to be presented at ASH 2017
December 04, 2017

Looking Beyond Risk in Risk-Based Monitoring, New Webinar Hosted by Xtalks
December 04, 2017

Two Rivers To Host Investor Conference Call
December 04, 2017

Trillium Announces Closing of Private Placement
December 01, 2017

Xtalks Announces its Webinars for December 2017
December 01, 2017

Maricann Group Inc. Files Third Quarter Financial Results, Updates Ongoing German License Progress and Distribution Efforts
December 01, 2017

Fresenius Medical Care achieves a milestone in expanding its Asian operations
November 30, 2017

INDIVA Corporation and Rainmaker Resources Ltd. Announce Filing Statement In Respect of Reverse Takeover Acquisition
November 30, 2017

CBIS Reports Honorable Judge Kimberly Mueller, Appointed by Former President Barack Obama, Sets Temporary Restraining Order Hearing for Today, Thursday, November 30, 2017 at 3:30pm in Department 3 of the US District Courthouse, 501 I Street, Sacramento, CA
November 30, 2017

The Alliance for Regenerative Medicine Announces 2018 Cell & Gene Therapies State of the Industry Briefing
November 30, 2017

EnWave Ends Investor Relations Contract
November 30, 2017

Neptune Receives Nasdaq Notification Confirming that it has Regained Compliance with Minimum Bid Requirements
November 30, 2017

Maricann Group Inc. Signs Letter of Intent with ABLE BC
November 30, 2017

ICC International Cannabis Corporation Files Financial Results for the Third Quarter Ended September 30, 2017
November 29, 2017

Revive Therapeutics Announces Results for the Three Months Ended September 30, 2017
November 29, 2017